Hillsdale Investment Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-365,800
| Closed | -$3.91M | – | 615 |
|
|
2024
Q3 | $3.91M | Buy |
365,800
+94,000
| +35% | +$1M | 0.3% | 128 |
|
|
2024
Q2 | $2.7M | Sell |
271,800
-48,000
| -15% | -$476K | 0.21% | 171 |
|
|
2024
Q1 | $3.77M | Buy |
319,800
+25,500
| +9% | +$300K | 0.3% | 138 |
|
|
2023
Q4 | $4.18M | Buy |
294,300
+23,640
| +9% | +$335K | 0.34% | 98 |
|
|
2023
Q3 | $3.29M | Buy |
270,660
+180
| +0.1% | +$2.19K | 0.3% | 131 |
|
|
2023
Q2 | $3.4M | Sell |
270,480
-130,320
| -33% | -$1.64M | 0.31% | 136 |
|
|
2023
Q1 | $4.44M | Buy |
400,800
+700
| +0.2% | +$7.76K | 0.38% | 93 |
|
|
2022
Q4 | $4.89M | Buy |
+400,100
| New | +$4.89M | 0.41% | 73 |
|